𝔖 Bobbio Scriptorium

✦ LIBER ✦

S24 Adjuvant Endocrine Therapies for PostmenopausalWomen: Standards and Not

✍ Scribed by M. Castiglione-Gertsch

Book ID: 114315712
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 155 KB
Volume: 14
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(05)80025-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant endocrine therapies for postmen

Adjuvant endocrine therapies for postmenopausal women with early breast cancer: Standards and not

✍ Silvia Dellapasqua; Monica Castiglione-Gertsch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Adjuvant systemic therapies for patients

Adjuvant systemic therapies for patients with breast cancer: Endocrine responsiveness and effects of chemotherapy

✍ Marco Colleoni; Aron Goldhirsch 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Letrozole's superiority over progestins

Letrozole's superiority over progestins and tamoxifen challenges standards of care in endocrine therapy for metastatic breast cancer

✍ M.J Piccart; F Cardoso; G Atalay 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Pegylated interferon alfa 2B (PEG-IFN) a

Pegylated interferon alfa 2B (PEG-IFN) and ribavirin for hepatitis C patients who were previous nonresponders to standard combination therapy: 24 week viral clearance: Eric J Lawitz, Brooke Army Medical Ctr, SanAntonio, TX; Mark A Jeffries, Wilford Hall USAF Medical Center, San Antonio, TX; Norma S Cantu, Shailesh C Kadakia, The Alamo Study Group, Brooke Army Medical Ctr, San Antonio, TX

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB